Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg
This study has been completed.
Sponsor:
Mylan Pharmaceuticals
Information provided by:
Mylan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00648063
First received: March 30, 2008
Last updated: November 30, 2009
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2006 |
| Primary Completion Date: | December 2005 (Final data collection date for primary outcome measure) |